Stay updated on ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial
Sign up to get notified when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.
Latest updates to the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page
- Check7 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check43 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference2%
- Check57 days agoChange DetectedThe website has added a 'Show less' option, while several detailed data fields and download options related to study information have been removed.SummaryDifference3%
- Check64 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading study data in various formats and displaying detailed participant and study information, while removing the option to show less content.SummaryDifference3%
- Check79 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.0%
Stay in the know with updates to ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.